BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260227T090000
DTEND;TZID=Europe/Stockholm:20260227T094000
DTSTAMP:20260507T133045
CREATED:20260123T100627Z
LAST-MODIFIED:20260206T071105Z
UID:193765-1772182800-1772185200@www.scilifelab.se
SUMMARY:FOCU.SE  - The Swedish national collaborative group for the implementation of comprehensive genetic profiling in patients with advanced cancer
DESCRIPTION:The programme includes a 40-minute talk followed by a 20-minute Q&A session \n\n\n\nBiography\n\n\n\nEdvard Abel\, MD\, PhD\, is a consultant in oncology at the Dep of Oncology at Sahlgrenska Comprehensive Cancer Center in Gothenburg. He holds the position of Centre Director at Sahlgrenska CCC\, as well as Medical Lead of the Phase I/First-in-Human trial unit at the Dep of Oncology. Dr Abel is the clinical principal investigator of the coming FOCU.SE trial\, a national collaboration between Genomic Medicine Sweden\, SciLifeLab and the oncological trial units\, among others.  \n\n\n\n\n\n\n\nAbstract\n\n\n\nThe FOCU.SE trial platform provides a nationwide clinical infrastructure for the implementation of PCM in Sweden. By enabling biomarker-guided use of approved drugs within a structured clinical trial framework and supporting systematic evaluation of clinical outcomes\, the platform aims to accelerate equitable access to personalised cancer therapy across healthcare regions. In parallel\, it generates high-quality real-world evidence to support regulatory decision-making and potential expansion of indications for targeted therapies \n\n\n\nAbout Clinical Talk\n\n\n\nClinical Talks returns with a new season! \n\n\n\nAfter seven successful seasons and over seventy dedicated speakers\, we are excited to continue showcasing the contributions of our diverse clinical\, academic\, and industry life science community. This season will feature ten insightful talks following our well-established format. \n\n\n\nThe overarching theme is “How to Achieve Feasible Implementation.” Sessions are held monthly \,usually on Fridays via Zoom\, with occasional exceptions. Each talk will be followed by an engaging Q&A session\, moderated by standing host Rikard Fred and a guest moderator with subject matter expertise to enrich the discussion. \n\n\n\nIn today’s rapidly evolving post-pandemic landscape\, exploring how academic\, clinical\, and industry research\, combined with technological advancements\, can drive practical and sustainable solutions is crucial. Join us for an opportunity to gain fresh insights\, expand your knowledge\, and connect with experts shaping the future of life sciences! \n\n\n\nClinical Talks are organised by SciLifeLab. \n\n\n\nLink to Registration
URL:https://www.scilifelab.se/event/focu-se-the-swedish-national-collaborative-group-for-the-implementation-of-comprehensive-genetic-profiling-in-patients-with-advanced-cancer/
CATEGORIES:Event
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
LOCATION:
END:VEVENT
END:VCALENDAR